Merck KGaA Statistics
Total Valuation
Merck KGaA has a market cap or net worth of 61.57 billion. The enterprise value is 69.52 billion.
| Market Cap | 61.57B |
| Enterprise Value | 69.52B |
Important Dates
The next estimated earnings date is Thursday, March 6, 2025.
| Earnings Date | Mar 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.16% |
| Shares Change (QoQ) | +0.32% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 129.20M |
Valuation Ratios
The trailing PE ratio is 20.48.
| PE Ratio | 20.48 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 12.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.74, with an EV/FCF ratio of 23.95.
| EV / Earnings | 23.12 |
| EV / Sales | 3.17 |
| EV / EBITDA | 12.74 |
| EV / EBIT | 18.85 |
| EV / FCF | 23.95 |
Financial Position
The company has a current ratio of 1.33, with a Debt / Equity ratio of 0.40.
| Current Ratio | 1.33 |
| Quick Ratio | 0.80 |
| Debt / Equity | 0.40 |
| Debt / EBITDA | 2.18 |
| Debt / FCF | 4.38 |
| Interest Coverage | 14.89 |
Financial Efficiency
Return on equity (ROE) is 9.54% and return on invested capital (ROIC) is 5.58%.
| Return on Equity (ROE) | 9.54% |
| Return on Assets (ROA) | 4.41% |
| Return on Invested Capital (ROIC) | 5.58% |
| Return on Capital Employed (ROCE) | 8.89% |
| Revenue Per Employee | 375,561 |
| Profits Per Employee | 48,300 |
| Employee Count | 62,908 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 1.84 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -17.39% in the last 52 weeks. The beta is 0.74, so Merck KGaA's price volatility has been lower than the market average.
| Beta (5Y) | 0.74 |
| 52-Week Price Change | -17.39% |
| 50-Day Moving Average | 146.82 |
| 200-Day Moving Average | 166.57 |
| Relative Strength Index (RSI) | 43.49 |
| Average Volume (20 Days) | 286 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Merck KGaA had revenue of 23.38 billion and earned 3.01 billion in profits. Earnings per share was 6.90.
| Revenue | 23.38B |
| Gross Profit | 13.75B |
| Operating Income | 3.93B |
| Pretax Income | 3.76B |
| Net Income | 3.01B |
| EBITDA | 5.66B |
| EBIT | 3.93B |
| Earnings Per Share (EPS) | 6.90 |
Balance Sheet
The company has 4.31 billion in cash and 12.71 billion in debt, giving a net cash position of -8.40 billion.
| Cash & Cash Equivalents | 4.31B |
| Total Debt | 12.71B |
| Net Cash | -8.40B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 31.67B |
| Book Value Per Share | 72.63 |
| Working Capital | 3.87B |
Cash Flow
In the last 12 months, operating cash flow was 4.92 billion and capital expenditures -2.01 billion, giving a free cash flow of 2.90 billion.
| Operating Cash Flow | 4.92B |
| Capital Expenditures | -2.01B |
| Free Cash Flow | 2.90B |
| FCF Per Share | n/a |
Margins
Gross margin is 58.80%, with operating and profit margins of 16.83% and 12.86%.
| Gross Margin | 58.80% |
| Operating Margin | 16.83% |
| Pretax Margin | 16.07% |
| Profit Margin | 12.86% |
| EBITDA Margin | 24.20% |
| EBIT Margin | 16.83% |
| FCF Margin | 12.42% |
Dividends & Yields
Merck KGaA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 38.24% |
| Buyback Yield | -0.16% |
| Shareholder Yield | -0.16% |
| Earnings Yield | 4.88% |
| FCF Yield | 4.72% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Merck KGaA has an Altman Z-Score of 3.23.
| Altman Z-Score | 3.23 |
| Piotroski F-Score | n/a |